GIG Gulf Secures Category “A” Health License in Oman
GIG Gulf has achieved a landmark milestone in Oman, becoming one of the first insurers to be awarded a Category “A” license by the Financial Services...
Category : Healthcare and Pharmaceutical
Dizal to Present Cancer Drug Advances at ASCO 2025
Dizal, a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced today that it will present latest clinical...
AI and the Biopharma Industry: Breaking Barriers and Navigating Challenges
The combination of AI and biopharmaceuticals is causing major changes in healthcare and life sciences. In biopharma, AI plays an important role from the beginning...
Anthem Blue Cross, Resurgens Orthopaedics Sign Multi-Year Deal
Resurgens to remain in-network for Anthem members across Georgia Anthem Blue Cross and Blue Shield announced today a new, multi-year provider network agreement with Resurgens...
Ceresti Health Opens Medicare GUIDE ‘Wait List’ for Dementia Care
Ceresti Health, the nation’s leading tech-enabled dementia care provider, has opened a digital health “wait list” for people in all 50 states on traditional Medicare...
Curative Launches Curative Telehealth, Future of Virtual Care
Instant Access Telehealth – Effortless $0 Virtual Care Anytime, Anywhere Curative Health Insurance Company, a leader in healthcare innovation, announced the launch of Curative Telehealth,...
Millions at Risk: Komen Speaks Out Against House Reconciliation Bill
Breast cancer patients could lose coverage, face delays in critical care Susan G. Komen, the world’s leading nonprofit breast cancer organization, is deeply troubled by...
Anthem Blue Cross & Capital Women’s Care Announce Multi-Year Deal
Capital Women’s Care to remain in-network for Anthem members across northern Virginia Anthem Blue Cross and Blue Shield in Virginia announced today a new, multi-year...
Celltrion’s YUFLYMA® Receives FDA Interchangeability Designation
Celltrion, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted an expanded interchangeable designation for YUFLYMA® (adalimumab-aaty), now including prefilled syringe (40mg)...
AnnJi Pharma Announces Positive Phase 1/2a Results for AJ201
AnnJi Pharmaceutical Co., Ltd., a clinical-stage Taiwanese biotechnology company focused on addressing unmet medical needs in dermatology, neurology, and rare diseases, today announced positive results...
PROVISION Study Shows Similar Outcomes for FFRangio and FFR
PROVISION Study, Prospective Randomized Trial Evaluating Clinical Outcomes of FFRangio Versus FFR Guidance, Demonstrates Similar MACE Rates at One Year Today at the annual EuroPCR...
Ascletis Announces FDA Clearance for ASC50 Psoriasis Trial
ASC50 is an in-house discovered and developed oral small molecule interleukin-17 (IL-17) inhibitor for the treatment of multiple autoimmune and inflammatory diseases, including psoriasis. Following...
Medecision Report: Gap Between Digital Care Management Reality
Survey of Health Plan Leaders Uncovers Critical Gaps—and a Path Forward A new report from Medecision, Building the Intelligent Health Plan, reveals a clear message from health...
ANTECH Launches RapidRead Dental, AI Tool for Vet Dentistry
ANTECH, a global veterinary diagnostics, technology and imaging company, today announced the launch of RapidRead Dental, an Artificial Intelligence (AI) powered radiology interpretation tool, that delivers...
Reperio Health Raises $14M to Expand At-Home Preventive Care
Company has tripled preventive care participation rates and is now expanding its AI-assisted, real-time virtual care feature nationwide. Reperio Health, the only provider of at-home...